PLOD1 and nonpapillary renal cell carcinoma: The extensive molecular interactions demonstrating stable binding of acetaminophen within PLOD proteins’ active sites, coupled with our comprehensive findings, establish PLOD genes as crucial players in ccRCC pathogenesis with significant clinical potential - serving not only as diagnostic and prognostic biomarkers but also revealing acetaminophen as a promising PLOD modulator for therapeutic intervention.